EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Do anti-TNF agents and combination treatment increase postoperative complication risk?

Oya Yönal, Gülen Hatemi, Över Hamzaoğlu

The Turkish Journal of Gastroenterology · 2012

DOI: 10.4318/tjg.2012.0620 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Turkish Journal of Gastroenterology, 2012. Verfasst von Oya Yönal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Memorial Hospital, Piyalepaşa Bulvarı, 34385 Şişli, İstanbul, Turkey. oya.yonal@memorial.com.tr. Hauptthemen laut MEDLINE: Colitis, Ulcerative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeAntibodies, MonoclonalDrug Therapy, CombinationGastrointestinal AgentsHumansImmunosuppressive AgentsInfliximabPostoperative ComplicationsRisk FactorsTumor Necrosis Factor-alpha

Substanzen

Antibodies, MonoclonalGastrointestinal AgentsImmunosuppressive AgentsTumor Necrosis Factor-alphaInfliximab

Autor:innen und Institutionen

  • Department of Gastroenterology, Memorial Hospital, Piyalepaşa Bulvarı, 34385 Şişli, İstanbul, Turkey. oya.yonal@memorial.com.tr

Zitieren

APA

Yönal, O., Hatemi, G., & Hamzaoğlu, Ö. (2012). Do anti-TNF agents and combination treatment increase postoperative complication risk?. The Turkish Journal of Gastroenterology. https://doi.org/10.4318/tjg.2012.0620

Vancouver

Yönal O, Hatemi G, Hamzaoğlu Ö. Do anti-TNF agents and combination treatment increase postoperative complication risk?. The Turkish Journal of Gastroenterology. 2012. doi:10.4318/tjg.2012.0620

BibTeX
@article{Ynal2012,
  author = {Yönal, Oya and Hatemi, Gülen and Hamzaoğlu, Över},
  title = {Do anti-TNF agents and combination treatment increase postoperative complication risk?},
  journal = {The Turkish Journal of Gastroenterology},
  year = {2012},
  doi = {10.4318/tjg.2012.0620}
}
Kostenlos starten →